Cloning, expression and characterization of a human dopamine D4.2 receptor (CHO K1 cells) and various D4.2/D(2L) chimeras (COS-7 cells)

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 21, Issue 1, 1997, Pages 153-167

  Shih, Yu Hsin ^a   Chung, Fu Zon ^a   Pugsley, Thomas A ^a  

^a PFIZER INC   (United States)

Author keywords

binding; chimeric receptors; expression; G protein regulation; human dopamine D4.2 receptor; polymerase chain reaction

Indexed keywords

2 DIPROPYLAMINO 5 METHOXY 1 METHYLTETRALIN; 5 METHOXY 1 METHYL 2 PROPYLAMINOTETRALIN; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; APOMORPHINE; BUTACLAMOL; CHLORPROMAZINE; CLOZAPINE; DOPAMINE 4 RECEPTOR; HALOPERIDOL; PROPYLNORAPOMORPHINE; QUINPIROLE; RACLOPRIDE; SPIPERONE; TALIPEXOLE; THIORIDAZINE; TRIFLUOPERAZINE;

ARTICLE; CLONING; DRUG BINDING; GENE EXPRESSION; HUMAN; HUMAN CELL; ISOTOPE LABELING;

ANIMALS; CHO CELLS; CLONING, MOLECULAR; COS CELLS; CRICETINAE; GENE EXPRESSION; HUMANS; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D4;

EID: 0031002585     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(96)00168-6     Document Type: Article

References (31)

1. 4 receptor repeat: analysis of different native and mutant forms of the human and rat genes. Mol. Pharmacol. 46: 364-373.
2. 4 dopamine receptors. Soc. for Neurosci. 21: 621.
3. 3 receptors. Neuropsychopharmacol. 12: 335-345.
4. 50) of an enzymatic reaction. Biochem. Pharmacol. 22: 3099-310.
5. 4 dopamine receptor-mediated signaling events determined in transfected Chinese hamster ovary Cells. J. Biol. Chem. 269: 11813-11819.
6. COX, B. A., HENNINGSEN, R. A., SPANOYANNIS, A., NEVE, R. L. and NEVE, K. A. (1992) Contributions of conserved serine residues to the interactions of ligands with dopamine D2 receptors. J. Neurochem. 59: 627-635.
7. 2 receptor. Mol. Pharmacol. 40: 712-716.
8. DE KEYSER, J. (1993) Subtype and localization of dopamine receptors in human brain. Neurochem. Int. 22: 83-93.
9. HORTON, R. M., HUNT, H. D., HO, S. N., PULLEN, J. K., and PEASE, L. R. (1989) Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene 77: 61-68.
10. JACKSON, D. M. and WESTLIND-DANIELSSON, A. (1994) Dopamine receptors: molecular biology, biochemistry and behavioural aspects. Pharmac. Ther. 64: 291-369.
11. 2- adrenergic receptors: delineation of domains involved in effector coupling and ligand binding specificity. Science 240: 1310-1316.
12. 2 dopamine receptors distinct determinants of selective efficacy, potency, and signal transduction. J. Biol. Chem. 269: 30299-30306.
13. 2 receptor selectivity of dopamine receptor antagonists: Possible therapeutic implications. Eur. J. Pharmacol. 236: 483-486.
14. 4 receptor expressed in HEK293 cells. Meth. Find. Exp. Clin. Pharmacol. 16: 303-307.
15. LIU, J., SCHÖNEBERG, T., VAN RHEE, M., and WESS, J. (1995) Mutational analysis of the relative orientation of transmembrane helices I and VII in G protein-coupled receptors. J. Biol. Chem. 270: 19532-19539.
16. 2 receptor. Eur. J. Pharmacol. Mol. Pharmacol. Sect. 227: 205-214.
17. MUNSON, P. J., and RODBARD, D. (1980) LIGAND: A versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem. 107: 220-239.
18. 2 receptor affinity for drugs and inhibition of adenylyl cyclase. Mol. Pharmacol. 39: 733-739.
19. O'DOWD, B. F. (1993) Structures of dopamine receptors. J. Neurochem 60: 804-816.
20. PITTEL Z., and WESS J. (1994) Intramolecular interactions in muscarinic acetylcholine receptors studies with chimeric m2/m5 receptors. Mol. Pharmacol. 45: 61-64.
21. PUGSLEY, T. A., DAVIS, M. D., AKUNNE, H. C., MACKENZIE, R. G., SHIH, Y. H., DAMSMA, G., WIKSTROM, H., WHETZEL, S. Z., GEORGIC, L. M., COOKE, L. W., DEMATTOS, S. B., CORBIN, A. E., GLASE, S. A., WISE, L. D., DUKSTRA, D. and HEFFNER, T. G. (1995) Neurochemical and functional characterization of the preferentially selective dopamine D3 agonist PD 128907. The J. of Pharmacol. Exp. Ther. 275: 1355-1366.
22. 4 receptors increased in schizophrenia? J. Neurochem. 63: 1576-1577.
23. 4 receptors in drug-treated schizophrenia. Eur. J. Pharm. 281: R5-R6.
24. 4 receptors elevated in schizophrenia. Nature 365: 441-445.
25. 4 receptors bind inactive (+)-aporphines, suggesting neuroleptic role. Sulpiride not stereoselective. Eur . J . Pharm. 233: 173-174.
26. 2 dopamine receptor. J. Biol. Chem. 257: 6351-6361.
27. SIBLEY, D.R., and MONSMA, F. J. JR. (1992) Molecular biology of dopamine receptors. Trends in Pharmacological Sci. 13: 61-69.
28. SURYANARAYANA, S., VON ZASTROW, M., and KOBILKA, K. (1992) Identification of intramoleclar interactions in adrenergic receptors. J. Biol. Chem. 267: 21991-21994
29. 4 dopamine receptors in fibroblast and dopaminergic cell lines. J. Pharmacol. Exp. Ther. 268: 495-502.
30. 4 receptor with high affinity for the antipsychotic clozapine. Nature 350: 610-614.
31. 2L dopamine receptor isoforms are differentially regulated in Chinese hamster ovary cells. Mol. Pharmacol. 45: 878-889.